HLA-C and prostate carcinoma: Numerous studies have demonstrated that a reduction in the expression of major histocompatibility complex (MHC) molecules enables tumor cells to evade detection and destruction by immune cells, thereby facilitating tumor proliferation and metastasis in cancers such as prostate cancer and melanoma.